Top Markets
Coin of the day
Carmell Therapeutics Corporation Carmell Therapeutics Corporation

Carmell Therapeutics Corporation

CTCX
Rangering i aksjer #36666
Carmell Therapeutics Corporation (CTCX) specializes in the creation of... Carmell Therapeutics Corporation (CTCX) specializes in the creation of plasma-based bioactive materials (PBMs) aimed at catalyzing tissue regeneration and repair following injury, illness, or the effects of aging. Their flagship product, CT-101, is a versatile accelerant with a dual focus. For orthopedic and dental applications, it's designed to enhance bone healing in cases such as tibia fractures, foot and ankle fusions, spinal fusions, and also serves as a dental bone graft substitute and bone void filler. Furthermore, CT-101 acts as a tissue healing accelerant, addressing conditions like androgenetic alopecia (pattern baldness) and persistent chronic wounds. Established in 2008, the company operates from its headquarters in Pittsburgh, Pennsylvania.
Aksjekurs
$0.117
Sist synkronisert: 2025-04-04
Markedsverdi
$2.45M
Endring (1 dag)
-13.59%
Endring (1 år)
0.00%
Land
US
Handel Carmell Therapeutics Corporation (CTCX)

Kategori

EPS for Carmell Therapeutics Corporation (CTCX)
EPS per June 2026 TTM: $-4.71
Ifølge de siste økonomiske rapportene og aksjekursen til Carmell Therapeutics Corporation er selskapets nåværende EPS (TTM) $-4.71. Ved slutten av 2023 hadde selskapet en EPS på $-0.74, en økning sammenlignet med EPS-en i 2022 som var $-0.50.
EPS-historikk for Carmell Therapeutics Corporation fra 2021 til 2026
EPS ved slutten av hvert år
År EPS Endre
2026 (TTM) $-4.71 842.00%
2024 $-0.50 -32.43%
2023 $-0.74 48.00%
2022 $-0.50 4,487.16%
2021 $-0.01 0.00%
EPS for lignende selskaper eller konkurrenter
Selskap EPS EPS-forskjell Land
$17.32 -467.73%
US
$27.74 -688.96%
NL
- -
CH
- -
KR
$13.70 -390.87%
BE